Full View

Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant

N Andrews, J Stowe, F Kirsebom, S Toffa… - … England Journal of …, 2022 - Mass Medical Soc
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
被引用次数：2088 相关文章

Covid-19 vaccine effectiveness against the omicron (B. 1.1. 529) variant

N Andrews, J Stowe, F Kirsebom… - … England Journal of …, 2022 - research-portal.uea.ac.uk
BACKGROUND: A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 in highly …

Covid-19 Vaccine Effectiveness against the Omicron (B. 1.1. 529) Variant

N Andrews, J Stowe, F Kirsebom, S Toffa… - New England Journal …, 2022 - cir.nii.ac.jp
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF] ellinikahoaxes.gr

[PDF][PDF] Covid-19 Vaccine Effectiveness against the Omicron (B. 1.1. 529) Variant

N Andrews, J Stowe, F Kirsebom, S Toffa… - N Engl J …, 2022 - media.ellinikahoaxes.gr
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant Page 1 The new
england journal of medicine n engl j med 386;16 nejm.org April 21, 2022 1532 The authors’ …

Covid-19 Vaccine Effectiveness against the Omicron (B. 1.1. 529) Variant

N Andrews, J Stowe, F Kirsebom… - The New England …, 2022 - pubmed.ncbi.nlm.nih.gov
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 in highly …

COVID-19 vaccine effectiveness against the omicron (B. 1.1. 529) variant.

N Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard… - 2022 - cabidigitallibrary.org
Background: A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
[PDF] amedeolucente.it

[PDF][PDF] Covid-19 Vaccine Effectiveness against the Omicron (B. 1.1. 529) Variant

N Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard… - 2022 - amedeolucente.it
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant Page 1 The new
england journal of medicine n engl j med nejm.org 1 The authors’ full names, academic degrees …

Covid-19 vaccine effectiveness against the omicron (B. 1.1. 529) variant

N Andrews, J Stowe, F Kirsebom… - … England Journal of …, 2022 - ueaeprints.uea.ac.uk
BACKGROUND: A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
[PDF] academia.edu

[PDF][PDF] Covid-19 Vaccine Effectiveness against the Omicron (B. 1.1. 529) Variant

N Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard… - 2022 - academia.edu
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant Page 1 The new
england journal of medicine n engl j med nejm.org 1 The authors’ full names, academic degrees …

Covid-19 Vaccine Effectiveness against the Omicron (B. 1.1. 529) Variant.

N Andrews, J Stowe, F Kirsebom, S Toffa… - The New England …, 2022 - europepmc.org
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 in highly …